- Entry
- $1,004.92
- Now
- $1,180.68 +17.5%
- Target
- —
- Score
- —
Compiled from official Q4 2025 earnings reports. Here is the full picture: 1. Johnson & Johnson: $94.2B 2. Roche: $79.3B 3. Eli Lilly: $65.2B (was $34B in 2023, nearly doubled in 2 years) 4. Pfizer: $62.6B 5. AbbVie: $61.2B 6. AstraZeneca: $58.7B 7. Merck: $58.1B (Keytruda alone: $31.7B) 8. Novartis: $54.5B 9. Sanofi: $51.6B (Dupixent: $18.5B) 10. Novo Nordisk: $49.0B (Ozempic + Wegovy drove this) * The biggest story here is Eli Lilly adding $30B in revenue in just 2 …
— ORIGINAL POST ·
Pharma sector 2025 revenue rankings are out. Eli Lilly's growth is the most remarkable story in big pharma history
· r/investing
· May 15, 2026